This is a report on the nature of the mutations in the PAX6 gene in twenty patients with aniridia. Five of the twenty patients had sporadic aniridia with deletions in chromosome 11p13. Three of the five had WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, mental retardation), and the o
Identification of a novel PAX6 gene mutation in an Aniridia patient
β Scribed by Iman Sahly; Marc Abitbol; Claudine Laurent; Imad Ghazi; Florence Ribeaudeau; Michel Vekemans; Jean-Louis Dufier
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 119 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
β¦ Synopsis
Aniridia is an autosomal dominant panocular disorder, characterized by hypoplasia of the iris. It is caused by mutations in the PAX6 gene. This gene encodes a 422-amino acid transcription factor. This protein includes paired and homeo domains, which bind DNA and a proline-serine and threonine-rich PST domain. Here we report an 8-bp duplication mutation (853ins8) in exon 10 within the PST domain of PAX6 in an aniridia patient. Instead of ACCTAGTCATATTCCT found in the normal PAX6 sequence, we found ACCTAGTCATAT-AGTCATAlTCCT in the mutant DNA. It disrupts codon 285 and causes a translational hameshift leading to a stop codon downstream. This results in the truncation of the C-terminal of PAX6 within the F' ST domain. Only four mutations were described so far in the PST domain of PAX6 in aniridia patients. They all leave the known DNA binding region intact, but truncate the protein and remove part of the PST-rich region. Recently, it was demonstrated that the PST domain is a strong transcriptional activator in vitro.
It stimulates the expression of a reporter gene when fused to the DNA-binding domain of the yeast GAL4 gene sequence .
If PAX6 is truncated within the PST domain, it may lack in vivo the transcriptional activiry of the PST domain. This would be sufficient to cause the aniridia phenotype.
π SIMILAR VOLUMES
We report two novel PAX6 mutations in aniridia patients of two Swiss pedigrees (We, Sc) which give rise to different phenotypes. An SSCP analysis of the PAX6 14 exons reveals electrophoretic mobility shifts exclusively in exons 5 and 12 of aniridia patients. As determined by bidirectional sequencing
Propionyl-CoA carboxylase (PCC) is a biotin-dependent enzyme located in the mitochondrial matrix. Mutations in the PCCA and PCCB genes, which encode the Ξ± Ξ± and Ξ² Ξ² subunits of this heteropolymer, result in propionic acidemia (PA). We report the molecular analysis of Ξ² Ξ²-deficient patients from Spai